Abstract: Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.

Abstract: Provided are antibodies specifically binding to the epidermal growth factor receptor (EGFR) which are effective for the treatment of EGFR-mediated cancers.

Abstract: Disclosed is a liquid crystal panel driving circuit of display stabilization, including: a plurality of output buffers buffering data voltage and supplying or cutting off the buffered data voltage to or from each of the plurality of data lines; an output MUX switch receiving outputs from two adjacent output buffers of the plurality of output buffers and transferring one of the two outputs to the plurality of data lines; a garbage switch connecting each of the plurality of data lines to a ground terminal; and a power on sensor or a power off sensor generating a power on or off reset signal in response to a turn on/off of a power supply voltage, wherein the output MUX switch is turned-off and the charge share switch and the garbage switch are turned-on, in response to the power on reset signal or the power off reset signal.

Abstract: Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.

Abstract: Provided are antibodies specifically binding to the epidermal growth factor receptor (EGFR) which are effective for the treatment of EGFR-mediated cancers.

Abstract: The present invention provides an antibody specifically binding to death receptor 5 (DR5), which is selected from the group consisting of: an antibody comprising a heavy chain variable region (VH) having the amino acid sequences of SEQ ID NOs: 1 to 3 at complementary determining regions (CDRs) and a light chain variable region (VL) having the amino acid sequences of SEQ ID NOs: 4 to 6 at CDRs; and an antibody comprising a (VH) having the amino acid sequences of SEQ ID NOs: 7 to 9 at CDRs and a (VL) having the amino acid sequences of SEQ ID NOs: 10 to 12 at CDRs, and a composition for preventing or treating a cancer comprising the same. The antibody of the present invention can be effectively used for the prevention or treatment of various cancers, through inducing autophagic cell death of TRAIL-sensitive cancer cells as well as TRAIL-resistant cancer cells by specific binding to DR5.

Abstract: The present invention provides an antibody specifically binding to death receptor 5 (DR5), which is selected from the group consisting of: an antibody comprising a heavy chain variable region (VH) having the amino acid sequences of SEQ ID NOs: 1 to 3 at complementary determining regions (CDRs) and a light chain variable region (VL) having the amino acid sequences of SEQ ID NOs: 4 to 6 at CDRs; and an antibody comprising a (VH) having the amino acid sequences of SEQ ID NOs: 7 to 9 at CDRs and a (VL) having the amino acid sequences of SEQ ID NOs: 10 to 12 at CDRs, and a composition for preventing or treating a cancer comprising the same. The antibody of the present invention can be effectively used for the prevention or treatment of various cancers, through inducing autophagic cell death of TRAIL-sensitive cancer cells as well as TRAIL-resistant cancer cells by specific binding to DR5.

Abstract: Disclosed is a thermoplastic elastomer composition comprising 100 parts by weight of EPDM rubber, 5-1,000 parts by weight of styrenic thermoplastic elastomer, 50-3,000 parts by weight of paraffin oil, 10-200 parts by weight of a polyolefin resin as a curative, 1-15 parts by weight of a phenolic resin, and 0.5-5 parts by weight of a curing activator. The composition is superior in flowability, mechanical properties and oil resistance as well as being low in hardness, so that it can be applied for automobile parts.

Abstract: Disclosed is a thermoplastic elastomer composition comprising 100 parts by weight of EPDM rubber, 5-1,000 parts by weight of styrenic thermoplastic elastomer, 50-3,000 parts by weight of paraffin oil, 10-200 parts by weight of a polyolefin resin as a curative, 1-15 parts by weight of a phenolic resin, and 0.5-5 parts by weight of a curing activator. The composition is superior in flowability, mechanical properties and oil resistance as well as being low in hardness, so that it can be applied for automobile parts.

Abstract: A method and apparatus for synchronization control of multimedia objects in an MHEG engine are specified. The present system overcomes the shortcomings in the conventional apparatus, which is the fact that interactive processing is not allowed during presentation and that the conventional apparatus cannot control synchronized presentation for failing to provide control of the conditional, temporal, and spatial synchronization.

Abstract: A thermoplastic elastomeric composition, which comprises liquid 1,2-polybutadiene, EPDM rubber, a polyolefin resin, a curative system consisting of phenolic resin and peroxide, and a co-curing agent, the 1,2-polybutadiene and EPDM rubber being at least partially cured, shows well-balanced various properties including physical properties, elasticity and thermal resistance in addition to being superior in oil resistance at high temperatures and processability.